Hemodiafiltration: balancing clinical efficacy with planetary health

Area of Science:

• Nephrology
• Environmental Science
• Healthcare Sustainability

Background:

• High-dose hemodiafiltration (HDF) shows improved survival, as demonstrated by the 2023 CONVINCE trial.
• Growing awareness of healthcare's environmental footprint highlights the resource intensity of dialysis treatments.
• The climate crisis necessitates evaluating the environmental impact of medical innovations.

Purpose of the Study:

• To examine the environmental implications of adopting high-dose hemodiafiltration (HDF).
• To synthesize evidence on resource consumption associated with HDF.
• To explore emerging sustainability solutions in nephrology within the context of climate change.

Main Methods:

• Review of life cycle assessments comparing HDF and conventional hemodialysis.
• Analysis of resource consumption data for HDF and alternative technologies.
• Synthesis of recent evidence on water and energy usage in dialysis.

Main Results:

• HDF exhibits a 30-40% higher carbon footprint and increased annual water consumption compared to conventional hemodialysis.
• Expanded hemodialysis (HDx) with medium cut-off membranes shows potential for reduced water and energy use.
• Water conservation technologies can decrease environmental impact by 30-50% without affecting patient outcomes.

Conclusions:

• HDF adoption presents a challenge for sustainable healthcare innovation.
• Technological advancements like HDx and water conservation offer promising environmental benefits.
• Nephrology must integrate environmental impact assessments and sustainable practices into patient care and technology evaluation.